Around Fairweather Image
Important Dates

2012

22-27 July, 19th International AIDS Conference 2012, Washington DC, US (website)

 

11-15 November, 11th International Congress on Drug Therapy in HIV Infection (HIV11), Glasgow, UK (website)

 

2013

30 June– 3 July, 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Kuala Lumpur, Malaysia (website)

 




Select Language

About EuroCoord

 

EuroCoord is a Network of Excellence established by several of the biggest HIV cohorts and collaborations within Europe - CASCADE, COHERE, EuroSIDA, and PENTA.

 

This large, integrated network exploits the scientific strengths of each collaboration to ensure that the best, most competitive HIV research is performed.

 

The main advantage of this collaborative method of working is the formation of a common virtual database, which currently has access to data from over 250,000 HIV positive people from many different settings in Europe and beyond.

 

EuroCoord is made up of 23 beneficiaries chosen from 16 countries to ensure representativeness across Europe. The nature of the collaboration means that apart from these partners, there is also an associated network of numerous affiliated sites – more than 100 collaborating centres, or third parties.

 

The tasks of EuroCoord are organised into 15 different workpackages, all of which are interrelated, and unified through the scientific oversight workpackage.

 

EuroCoord is funded for a period of 5 years as part of the European Commission’s Framework Programme 7.

 

. More information about the aims of EuroCoord

. Download the EuroCoord briefing document

 

Latest News

Mortality rates in certain groups of HIV positive people on treatment are similar to those in the general population

 

A study by COHERE in EuroCoord has shown that mortality patterns in treated HIV positive people with a high CD4 count who are not injecting drug users are similar to those in the general population.

 

EuroCoord methodology subgroup

 

During the methodology symposium which took place in London in December 2011, the group announced that they will provide a methodology service to investigators across the participating networks.

 

 

No evidence of clinical benefit for patients starting treatment with a healthy immune system

 

A paper published by the CASCADE Collaboration in EuroCoord has found no evidence of clinical benefit for patients starting HIV treatment at higher CD4 cell counts of between 500-799 cells/mm3.

  

 
| Home Page | Site Map | Search | FAQ | Feedback | List Access Keys |